Systemic Polyarteritis Nodosa
Watchlist
Retrieved
2021-01-23
Source
Trials
—
Genes
ADA2,
TP53,
ACTB,
MEFV,
TNF,
KRAS,
CIP2A,
HHLA2,
PRPF8,
DLEU1,
ADGRG1,
PTTG1,
SF3B1,
WASF1,
INPP4B,
VEGFA,
TRE-TTC3-1,
HSP90B2P,
TREH,
ACR,
TERT,
CD274,
HSPA14,
CLDN18,
CHMP3,
CRTAC1,
FBXW7,
ERAP2,
SLFN11,
PCAT4
ADA2,
TP53,
ACTB,
MEFV,
TNF,
KRAS,
CIP2A,
HHLA2,
PRPF8,
DLEU1,
ADGRG1,
PTTG1,
SF3B1,
WASF1,
INPP4B,
VEGFA,
TRE-TTC3-1,
HSP90B2P,
TREH,
ACR,
TERT,
CD274,
HSPA14,
CLDN18,
CHMP3,
CRTAC1,
FBXW7,
ERAP2,
SLFN11,
PCAT4,
POTED,
MACC1,
MIR30A,
LOC100288966,
BLACAT1,
GCA,
RPS19,
CX3CL1,
PRMT2,
ADA,
ADAM10,
BCL6,
BRCA1,
ENTPD5,
CDC20,
COL11A1,
CSF2,
CTLA4,
CTNNB1,
ELF3,
ESRRA,
F2,
HMGB1,
HSPD1,
RAD52,
IL1B,
IL2,
JAK1,
LAMP2,
LEP,
LEPR,
MCAM,
MET,
MMP8,
MPO,
MSN,
MYC,
NOTCH1,
PTEN,
LOC107985770
Drugs
—
Registered!
Systemic polyarteritis nodosa (PAN; see this term) is a chronic systemic necrotizingvasculitis of adults and childrenaffecting small- and medium-sized vessels and characterized by formation of microaneurysms leading to serious generalized disease and multi-organ involvement.